To assess the associations of semaglutide with recurrent AUD diagnosis (recurrent medical encounters for AUD diagnosis), the study population included 4254 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new-user design) prescribed semaglutide or non-GLP-1RA anti-obesity medications during 6/202112/2022 (index event), had a diagnosis of AUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities on or before the index event
PMC 3644392
How GLP-1 Medications Work GLP-1 (glucagon-like peptide-1) medications like Ozempic, Wegovy, and Saxenda have gained popularity for weight loss due to their ability to: Suppress appetite : These medications work by mimicking the effects of a hormone that regulates hunger, helping you feel full for longer periods
A: We could send experience engineers on site to install the product and train your staff for equipment operation and maintenance
After reviewing new molecules for the ADA 2025 conference, Id be remiss to not review the new data and molecules of interest for Obesity Week 2025, especially since I actually went to the conference
Never adjust your dose or timing without professional oversight
